Henrik Jespersen

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Topics

Monoclonal Antibody

Histone Deacetylase

Top Venues

Cancer research communications

Nature communications

Acta oncologica (Stockholm, Sweden)

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Lars Ny, Henrik Jespersen, Joakim Karlsson, Samuel Alsén, Stefan Filges, Charlotta All-Eriksson, Bengt Andersson, Ana Carneiro, Hildur Helgadottir, Max Levin, Ingrid Ljuslinder, Roger Olofsson Bagge, Vasu R Sah, Ulrika Stierner, Anders Ståhlberg, Gustav Ullenhag, Lisa M Nilsson, Jonas Andreas Nilsson
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma. Nature communications 12 (1) (2021)
Carl-Jacob Holmberg, Dimitrios Katsarelias, Henrik Jespersen, Ana Carneiro, Nils O Elander, Hildur Helgadottir, Karolin Isaksson, Malin Jansson, Sara Wirén, Gustav J Ullenhag, Lars Ny, Roger Olofsson Bagge
Surgery of metastatic melanoma after systemic therapy - the SUMMIST trial: study protocol for a randomized controlled trial. Acta oncologica (Stockholm, Sweden) 60 (1) (2020)
Joakim Karlsson, Lisa M Nilsson, Suman Mitra, Samuel Alsén, Ganesh Vilas Shelke, Vasu R Sah, Elin M V Forsberg, Ulrika Stierner, Charlotta All-Eriksson, Berglind Einarsdottir, Henrik Jespersen, Lars Ny, Per Lindnér, Erik Larsson, Roger Olofsson Bagge, Jonas Andreas Nilsson
Molecular profiling of driver events in metastatic uveal melanoma. Nature communications 11 (1) (2020)
Anna Arheden, Joanna Skalenius, Sara Bjursten, Ulrika Stierner, Lars Ny, Max Levin, Henrik Jespersen
Real-world data on PD-1 inhibitor therapy in metastatic melanoma. Acta oncologica (Stockholm, Sweden) 58 (7) (2019)
Elin M V Forsberg, Mattias F Lindberg, Henrik Jespersen, Samuel Alsén, Roger Olofsson Bagge, Marco Donia, Inge Marie Svane, Ola Nilsson, Lars Ny, Lisa M Nilsson, Jonas A Nilsson
HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice. Cancer research 79 (5) (2019)
Henrik Jespersen, Mattias F Lindberg, Marco Donia, Elin M V Söderberg, Rikke Andersen, Ulrich Keller, Lars Ny, Inge Marie Svane, Lisa M Nilsson, Jonas A Nilsson
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model. Nature communications 8 (1) (2017)